Study Will Evaluate The Safety And Efficacy Of Anidulafungin In Patients With Candidemia Or Invasive CandidiasisAntimicrobial PK in Infants With Suspected or Confirmed InfectionAnidulafungin PK in Infants and ToddlersAnidulafungin vs Amphotericin B Safety in High Risk Hepatic Transplant RecipientsEffect of Weight and/or Obesity on Anidulafungin Drug ConcentrationsEfficacy of Interferon-gamma in Combination With Anidulafungin for the Treatment of CandidemiaPharmacokinetics of Anidulafungin (Ecalta ®) Intravenous Given to Patients at High Risk for Developing Invasive Fungal DiseaseA Study Of The Efficacy And Safety Of Anidulafungin Vs. Fluconazole In The Treatment Of Patients With Candidemia And/Or Other Forms Of Invasive CandidiasisAnidulafungin Candidemia/Invasive Candidiasis Intensive Care Studyβ-D-Glucan (BDG) Surveillance With Preemptive Anidulafungin vs. Standard Care for Invasive Candidiasis in Surgical Intensive Care Unit (SICU) PatientsAnidulafungin Pharmacokinetics Given as a Single Intravenous Dose to Obese Patients (ADOPT)Anidulafungin Pharmacokinetics in Intensive Care Unit PatientsVoriconazole And Anidulafungin Combination For Invasive Aspergillosis In Pediatric SubjectsEarly Clinical Experience With Anidulafungin In Patients With Liver Disease In The United KingdomPharmacokinetics of Anidulafungin on Intensive Care Unit (ICU)Anidulafungin in Patients With Hematologic MalignanciesCandida in the Respiratory Tract Secretions of Critically Ill Patients and The Efficacy of Antifungal TreatmentAnidulafungin During Continuous Venovenous Hemofiltration (CVVHF)Anidulafungin Versus Fluconazole for the Prevention of Fungal Infections in Liver Transplant RecipientsAn Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Serious Fungal Infection Due To Candida In Patients With A Dysfunctional Immune SystemAn Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Deep Tissue Infection Due To CandidaStudy To Assess Pharmacokinetics, Safety & Efficacy of Anidulafungin When Treating Children With Invasive CandidiasisStudy to Test the Combination of Voriconazole and Anidulafungin in Patients Who Have, or Are Thought to Have, Invasive Aspergillosis and Who Are Unable to Take a Common Antifungal Therapy (Polyene)A Study To Assess The Anidulafungin And Voriconazole Concentration In Lung Following Intravenous Administration In Healthy SubjectsThis Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive CandidiasisAnidulafungin In Treatment Of Candidemia In Asian SubjectsAnidulafungin Plus Voriconazole Versus Voriconazole For The Treatment Of Invasive AspergillosisAnidulafungin in Treating Immunocompromised Children With NeutropeniaAnidulafungin Versus Fluconazole in the Treatment of CandidemiaSafety, Tolerance and Pharmacokinetics of Anidulafungin in Immunocompromised Children Ages 2-17The Safety and Efficacy of Anidulafungin Versus Comparator in Patients With Candidemia and Invasive CandidiasisThe Safety and Efficacy of Intravenous Anidulafungin as a Treatment for Azole-Refractory Mucosal Candidiasis (FRMC)The Safety and Effectiveness of Intravenous Anidulafungin as a Treatment for Patients With Invasive Candidiasis.A Safety & Effectiveness Study of Intravenous Anidulafungin With AmBisome® for Treatment of Invasive Aspergillosis (IA).Negative Beta Glucan in ICU PatientsImpact of Capillary Leak and Hypoalbuminemia on PK/PD of Anidulafungin and Caspofungin in Critically Ill Patients
P4844
Anidulafungin: review of a new echinocandin antifungal agent.The echinocandins.Anidulafungin: a novel echinocandin for candida infections.Pharmacology and antifungal properties of anidulafungin, a new echinocandin.Low but sufficient anidulafungin exposure in critically ill patients.Pharmacological properties of antifungal drugs with a focus on anidulafungin.Anidulafungin, a new echinocandin: in vitro activity.Anidulafungin, a new echinocandin: effectiveness and tolerability.Anidulafungin versus fluconazole: clinical focus on IDSA and ESCMID guidelines.A rationale for reduced-frequency dosing of anidulafungin for antifungal prophylaxis in immunocompromised patients.Conclusions. Anidulafungin is a new echinocandin developed for more effective treatment of serious systemic fungal infections.Invasive Candidiasis in Infants and Children: Recent Advances in Epidemiology, Diagnosis, and TreatmentAnidulafungin (Eraxis) for Candida infections
P921
Q61917506-84B79958-EBC4-436F-BDD1-BE9ACA72E7ABQ61917969-9BF30D92-767A-4C78-9F29-C2E74BE996EAQ63063563-D0F21AA4-8D68-44DE-90B3-9DD5A049D342Q63337054-3F4BF219-0DBD-45CE-95C0-F2E8F73AB276Q63813723-746C81D7-2AE3-4CE7-8070-0E78B835C1C7Q63815964-64D6EC77-424A-4FBE-B1FD-F753320F8EBEQ63819111-21E968A1-56F4-4EDA-94CF-9F66CDE967E5Q63830019-C2B4267D-0189-4693-AC5C-65715E83D2F1Q64045114-9663DF66-FA9F-4063-BFC5-9DBE09DAF106Q64047351-BDC04D0B-7F9C-4BFF-B3D8-2EE6AF0F2AC2Q64350292-B10F7CAB-C812-4EB9-A998-D49113AA9314Q64647760-767345FC-BE4B-4C05-91BA-B0FBB0710A3BQ64653061-9740BF4E-6454-4424-8085-FADEABF32CD2Q64653067-80108B76-2F7E-4708-84CA-BD9E7D49F3C0Q64657687-A4DA2747-8BF3-4710-82C2-822C525841DDQ64658197-27E7D1CE-06E1-4BF0-BE6B-00AF96227CE6Q64673385-00ECE563-4396-433A-9C59-E2FD412B2F0EQ64677863-683104DA-10AC-4EAA-9D5F-C378D18F2E10Q64693757-AE51DF62-A620-4AEA-BF67-E908A44406CCQ64697573-71DDABB9-192D-4063-BF7B-390E829F05B1Q64697620-2ECA41B1-5198-4EFB-8BAE-5C9D7A7D5E1EQ64714908-CCD14FB6-5465-4F5B-B979-2D5419317DE6Q64722916-6D2521EC-6F19-4DE5-94EA-08142E7692ADQ65377983-8B857CAA-6346-42AC-9F77-08BBA7A1778DQ65379082-BA7497F4-6083-4235-BBD1-6AA9AF606DA7Q65380830-D890B554-C3C9-4D05-BBAB-A6B11C9451CAQ65472481-F8107BF1-E78D-4EA2-A06E-AEE63A66A560Q66034888-49DE90FF-F1AE-4702-B3F0-6D94B3587E44Q66036761-508B4917-8642-407E-9BB8-ABBCFF26F905Q66037094-4BA5D141-E0A6-42F8-AB1E-4E837C5AE298Q66037095-1D5DAD31-6016-403C-8E08-57148F61712CQ66038155-27B96211-F432-48F0-9739-DC413C90B95DQ66038602-11855DCE-522A-4EE6-A1C4-4401D10350DAQ66038604-8E776728-63EE-47C3-A498-E68152B17AD8Q66346214-0509B00A-B6F3-4011-81D2-8F5F3FE9C239Q66388139-A8B97C08-D690-45DD-B018-E0444700BEB9
P4844
Q35917456-E665E82D-EB07-48FB-8769-105A2A83567BQ36742397-A0FFD11E-9E89-41F6-AF41-CF889AE48D78Q37345790-C99BE51A-C960-4219-8956-D76A7F7AFDA9Q37359613-B02F03CD-0923-4CCE-B81E-E6D5698FFFEFQ37544395-D8943805-8C13-4D46-8B82-6688829D2F98Q37624716-AFF95F33-A95F-47C2-A631-6444A97E135BQ37624719-5AA3EFA9-4552-4F7F-B279-2C89D00A7D56Q37624721-129E75F2-4D14-4AAE-BF0C-60BE7FE8D467Q38222481-886E9770-F651-4F6D-99CA-8A6A47FFB52FQ38419657-796032AD-33EE-435D-B6F6-9A73C1C7CCFEQ43251797-71B015A6-2864-4CFD-B41E-DEEB169CDDAEQ64229011-02439D8A-8F71-4536-8992-E9D565DD1084Q83979102-9889077E-46C0-42F2-9180-910143D90552
P921
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Anidulafungin
@sh
Anidulafungin
@sr
Anidulafungin
@vi
Anidulafungină
@ro
anidulafungin
@en
anidulafungina
@pl
Анідулафунгін
@uk
أنيدولافنجين
@ar
type
label
Anidulafungin
@sh
Anidulafungin
@sr
Anidulafungin
@vi
Anidulafungină
@ro
anidulafungin
@en
anidulafungina
@pl
Анідулафунгін
@uk
أنيدولافنجين
@ar
altLabel
(4R,5R)-4,5-Dihydroxy-N²-[[4'' ...... -proline cyclic (6->1)-peptide
@en
Anidulafungin
@en
Anidulafungina
@en
Anidulafungine
@en
Anidulafunginum
@en
Eraxis
@en
V-Echinocandin
@en
prefLabel
Anidulafungin
@sh
Anidulafungin
@sr
Anidulafungin
@vi
Anidulafungină
@ro
anidulafungin
@en
anidulafungina
@pl
Анідулафунгін
@uk
أنيدولافنجين
@ar
P486
P592
P6366
P661
P662
P665
P683
P1579
P2017
CCCCCOC1=CC=C(C=C1)C2=CC=C(C=C ...... (C=C7)O)O)O)[C@@H](C)O)C)O)O)O
P2067
1,139.506294